The role of EGFR-targeting strategies in the treatment of head and neck cancer

Abstract

With its targeted mechanism of action and synergistic activity with current treatment modalities, cetuximab is a potentially valuable treatment option for patients with recurrent and/or metastatic squamous cell cancer of the head and neck who have progressed on cisplatin-based chemotherapy. The use of cetuximab in combination with radiotherapy as definitive… (More)
DOI: 10.2147/OTT.S31863

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Dequanter2012TheRO, title={The role of EGFR-targeting strategies in the treatment of head and neck cancer}, author={Didier Dequanter and Mohammad Shahla and Pascal Paulus and Philippe H Lothaire}, booktitle={OncoTargets and therapy}, year={2012} }